Home › Funds › ACT CAPITAL MANAGEMENT, LLC › MLYS
ACT CAPITAL MANAGEMENT, LLC position in MLYS
Mineralys Therapeutics, Inc. · Health Care
ACT CAPITAL MANAGEMENT, LLC reported holding 28,100 shares of MLYS (Mineralys Therapeutics, Inc.) in its Q2 2026 13F filing — a position valued at US$758K, representing 0.50% of its reported portfolio and ranking #32 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACT CAPITAL MANAGEMENT, LLC's MLYS position evolved
ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in MLYS in Q2 2026 at 28,100 shares (US$758K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 28.10K | $758.14K | New |
About MLYS and 13F data
MLYS (Mineralys Therapeutics, Inc.) is a Health Care company. 54 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MLYS
- RA CAPITAL MANAGEMENT, L.P. 7.69M sh · $207.55M · Q2 2026
- Catalys Pacific, LLC 7.80M sh · $196.00M · Q3 2026
- Samsara BioCapital, LLC 5.87M sh · $158.40M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.96M sh · $106.79M · Q2 2026
- Laurion Capital Management LP 2.51M sh · $67.62M · Q2 2026
- ORBIMED ADVISORS LLC 2.11M sh · $56.94M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.56M sh · $42.20M · Q2 2026
- Andera Partners 1.59M sh · $40.00M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.47M sh · $39.66M · Q2 2026
- Ghisallo Capital Management LLC 1.12M sh · $30.35M · Q2 2026
- Logos Global Management LP 1.05M sh · $28.33M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.04M sh · $28.06M · Q2 2026
More on ACT CAPITAL MANAGEMENT, LLC
FAQ
How long has ACT CAPITAL MANAGEMENT, LLC held MLYS?
ACT CAPITAL MANAGEMENT, LLC has disclosed MLYS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is ACT CAPITAL MANAGEMENT, LLC's current position in MLYS?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 28.10K shares of MLYS (Mineralys Therapeutics, Inc.), valued at $758.14K, representing 0.50% of its reported portfolio and ranking #32.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling MLYS?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC newly opened its position in MLYS.
Which other funds hold MLYS?
Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.